Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

Ferriman-Gallwey Score

Modified Ferriman-Gallwey

Hirsutism Score

0

NORMAL HAIR DISTRIBUTION

Validated for most ethnicities (Cut-off ≥8). Smaller thresholds may apply to certain populations (e.g. East Asian).

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

Primary Clinical Uses

Standardized visual assessment to quantify the severity of hirsutism in women
Fulfilling the clinical hyperandrogenism criteria for the diagnosis of Polycystic Ovary Syndrome (PCOS)
Monitoring therapeutic response to anti-androgen treatments or oral contraceptives

Patient Context

Hirsutism (excess terminal hair in a male-pattern distribution) is distinct from hypertrichosis (generalized excess hair everywhere). The FG score exclusively targets androgen-sensitive regions to differentiate the two.

How it Works

Scoring Logic

Evaluates terminal (dark, coarse) hair growth across 9 androgen-sensitive body areas. Each area is assigned a score from 0 (no terminal hair) to 4 (extensive visible hair). Maximum score is 36.

The 9 Assessment Areas

Upper Lip0-4 points
Chin0-4 points
Chest0-4 points
Upper Back0-4 points
Lower Back0-4 points
Upper Abdomen0-4 points
Lower Abdomen0-4 points
Upper Arms0-4 points
Thighs0-4 points

Clinical Pearls

Key Nuances

Highly subjective tool with notable inter-observer variability.
Recent hair removal (shaving, plucking, waxing, laser) drastically masks the true baseline score. Patients should ideally not perform hair removal for 4 weeks prior to assessment.
Racial and ethnic variations are critical: The normal density of body hair varies wildly by genotype. Standard cutoffs may drastically overdiagnose or underdiagnose hirsutism depending on the patient's heritage.

Modifications

The original 1961 score included 11 body parts. The "Modified" Ferriman-Gallwey score (mFG), universally used today, removed the lower leg and forearm areas, as hair in those regions is typically independent of androgen levels.

Next Steps

Interpretation and Action

01
Calculate total mFG Score.
02
Determine clinical hirsutism based on general cutoff (commonly ≥8, though ≥4-6 may be used in certain ethnic populations like East Asian women).
03
If positive and accompanying oligo/anovulation or PCO morphology: Meets Rotterdam criteria for PCOS.
04
Order biochemical evaluation: Total and Free Testosterone, DHEAS, 17-OH Progesterone (to rule out CAH).
05
If virilization is rapid or severe: Immediately screen for androgen-secreting ovarian or adrenal neoplasms.

The Evidence

Landmark References

Clinical assessment of body hair growth in women.

Ferriman D et al. • J Clin Endocrinol Metab.. 1961;Original publication introducing the scoring method.

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.

Martin KA et al. • J Clin Endocrinol Metab.. 2018;Validates the mFG score as the gold standard for clinical diagnosis of hirsutism and emphasizes population-specific thresholds.

Origins & History

Creators

Developed by Dr. David Ferriman and Dr. J.D. Gallwey in 1961. The current modified version (which dropped 2 regions to establish the 9-region standard) was later refined by Hatch et al. in 1981.

Last Comprehensive Review: 2026-07-17

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.